Literature DB >> 14684521

Sonographic, mammographic, and histopathologic correlation of symptomatic ductal carcinoma in situ.

Wei Tse Yang1, Gary M K Tse.   

Abstract

OBJECTIVE: The purpose of this study was to describe the features of symptomatic ductal carcinoma in situ (DCIS) of the breast shown on high-resolution sonography and to correlate them with findings from mammography and histopathology to evaluate the prognostic ability of sonographic findings.
MATERIALS AND METHODS: We retrospectively reviewed mammographic and sonographic images of 60 DCIS lesions from 55 symptomatic women. Images were reviewed by a radiologist who knew that the patients had DCIS but had no other information regarding pathology. Lesions were evaluated pathologically and classified using the Van Nuys classification system. Statistical comparisons were made using Fisher's exact test.
RESULTS: Of the 60 lesions, 33 were classified as Van Nuys group 1, 19 as Van Nuys group 2, and eight as Van Nuys group 3. Six (10%) of the 60 lesions were not visible on sonography, and 12 lesions (20%) were not visible on mammography. Sonography revealed a mass in 43 cases (72%), ductal changes in 14 cases (23%), and architectural distortion in four cases (7%). Eight lesions had more than one of these features. A sonographically visualized, irregularly shaped mass with indistinct or angular margins and no posterior acoustic shadowing or enhancement was associated with a high Van Nuys classification (p < 0.05). Microcalcifications were visible on sonography in 13 (22%) of the 60 lesions or on mammography in 25 lesions (42%). Both findings were associated with a high Van Nuys classification (p < 0.05).
CONCLUSION: Although sonography can reveal microcalcifications within masses, it is unreliable in depicting and characterizing the morphology and extent of microcalcifications, particularly when they are in isolation. Therefore, sonography should not be used to replace mammography but instead as an adjunctive tool to increase the sensitivity of mammography in breast diagnosis.

Entities:  

Mesh:

Year:  2004        PMID: 14684521     DOI: 10.2214/ajr.182.1.1820101

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  21 in total

1.  Role of ultrasound and sonographically guided core biopsy in the diagnostic evaluation of ductal carcinoma in situ (DCIS) of the breast.

Authors:  V Londero; C Zuiani; A Furlan; J Nori; M Bazzocchi
Journal:  Radiol Med       Date:  2007-09-20       Impact factor: 3.469

2.  Radiologic-pathological correlation of punctate hyperechoic foci by ultrasound in stereotactic vacuum-assisted breast biopsy samples.

Authors:  Hiroko Okazaki; Fumio Tsujimoto; Ichirou Maeda; Tomoyuki Ohta; Yoshihide Kanemaki; Kyoko Okamoto; Hiroshi Shimamoto; Yukari Yabuki; Haruki Ogata; Tomohiko Ohta; Mamoru Fukuda; Yasuo Nakajima
Journal:  Jpn J Radiol       Date:  2009-12-25       Impact factor: 2.374

Review 3.  Breast imaging in patients with nipple discharge.

Authors:  Ivie Braga de Paula; Adriene Moraes Campos
Journal:  Radiol Bras       Date:  2017 Nov-Dec

4.  VPAC1 receptors for imaging breast cancer: a feasibility study.

Authors:  Mathew L Thakur; Kaijun Zhang; Adam Berger; Barbara Cavanaugh; Sung Kim; Chaitra Channappa; Andrea J Frangos; Eric Wickstrom; Charles M Intenzo
Journal:  J Nucl Med       Date:  2013-05-07       Impact factor: 10.057

5.  Breast US in patients with breast cancer presenting as only microcalcifications on mammography: can US differentiate ductal carcinoma in situ from invasive cancer?

Authors:  Ji-Yeon Han; Jin Hwa Lee; Eun-Kyung Kim; Suyoung Shin; Myong Jin Kang; Keun-Cheol Lee; Kyung Jin Nam
Journal:  J Med Ultrason (2001)       Date:  2013-07-09       Impact factor: 1.314

6.  Category assessment based on 3D volume data acquired by automated breast ultrasonography.

Authors:  Mitsuhiro Tozaki; Eisuke Fukuma
Journal:  Jpn J Radiol       Date:  2011-12-17       Impact factor: 2.374

Review 7.  Advances in Breast MRI in the Setting of Ductal Carcinoma In Situ.

Authors:  Nita Amornsiripanitch; Diana L Lam; Habib Rahbar
Journal:  Semin Roentgenol       Date:  2018-08-30       Impact factor: 0.800

8.  Clinicopathologic, mammographic, and sonographic features in 1,187 patients with pure ductal carcinoma in situ of the breast by estrogen receptor status.

Authors:  Gaiane M Rauch; Henry M Kuerer; Marion E Scoggins; Patricia S Fox; Ana P Benveniste; Young Mi Park; Sara A Lari; Brian P Hobbs; Beatriz E Adrada; Savitri Krishnamurthy; Wei T Yang
Journal:  Breast Cancer Res Treat       Date:  2013-06-18       Impact factor: 4.872

9.  Analysis of false-negative results after US-guided 14-gauge core needle breast biopsy.

Authors:  Ji Hyun Youk; Eun-Kyung Kim; Min Jung Kim; Jin Young Kwak; Eun Ju Son
Journal:  Eur Radiol       Date:  2009-10-28       Impact factor: 5.315

10.  Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating peptide (PACAP) receptor specific peptide analogues for PET imaging of breast cancer: In vitro/in vivo evaluation.

Authors:  Kaijun Zhang; Mohan R Aruva; Nylla Shanthly; Christopher A Cardi; Chirag A Patel; Satish Rattan; Gregory Cesarone; Eric Wickstrom; Mathew L Thakur
Journal:  Regul Pept       Date:  2007-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.